AI Science Tracker
EN

Training and validation of a novel non-invasive imaging system for ruling out malignancy in canine subcutaneous and cutaneous masses using machine learning in 664 masses

HT BioImaging Ltd., Israel · 29 Sep 2023 · medicine

Discovery

Training and validation of a novel non-invasive imaging system for ruling out malignancy in canine subcutaneous and cutaneous masses using machine learning in 664 masses

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Prospective fixed-algorithm thermography validation against cytology/histopathology in 299 dogs/525 masses; 45/53 malignant and 253/378 benign correctly classified (sensitivity 85%, specificity 67%, NPV 97%; eight false negatives were mast cell tumors). The result is limited to the reported study population and evaluation; the source does not establish transfer to other populations or improved clinical outcomes.

Technology: Fixed machine-learning thermography classifier for canine masses

Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.

AI contribution
Fixed machine-learning thermography classifier for canine masses
Limitation / still unknown
The study does not establish improved patient outcomes or generalization beyond the evaluated setting.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2023.1164438/full · https://doi.org/10.3389/fvets.2023.1164438

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 4/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.